TABLE 1.
In vitro activities of telavancin and comparators against gram-positive bacteria
Organism (no. of strains) and antimicrobial agent | MIC (mg/liter)
|
||
---|---|---|---|
Range | 50% | 90% | |
Staphylococcus aureus | |||
Methicillin susceptible (60) | |||
Telavancin | 0.06-0.5 | 0.25 | 0.25 |
Vancomycin | 0.5-2 | 0.5 | 1 |
Teicoplanin | 0.25-4 | 0.5 | 1 |
Daptomycin | 0.12-0.5 | 0.25 | 0.5 |
Oxacillin | ≤0.06-2 | 0.25 | 0.5 |
Erythromycin | ≤0.12->16 | 0.5 | >16 |
Telithromycin | 0.06->8 | 0.12 | 0.12 |
Clindamycin | ≤0.5->4 | ≤0.5 | ≤0.5 |
Quinupristin-dalfopristin | ≤0.12-0.5 | 0.25 | 0.25 |
Linezolid | ≤0.5-4 | 2 | 2 |
Ciprofloxacin | 0.12->8 | 0.25 | 1 |
Trimethoprim-sulfamethoxazole | ≤0.5-2 | ≤0.5 | ≤0.5 |
Gentamicin | ≤0.06->16 | 0.25 | 1 |
Methicillin resistant (40) | |||
Telavancin | 0.06-0.5 | 0.25 | 0.25 |
Vancomycin | 0.5-2 | 1 | 1 |
Teicoplanin | ≤0.12-4 | 0.5 | 4 |
Daptomycin | 0.12-1 | 0.5 | 0.5 |
Oxacillin | 4->4 | >4 | >4 |
Erythromycin | ≤0.12->16 | >16 | >16 |
Telithromycin | ≤0.03->8 | 0.12 | >8 |
Clindamycin | ≤0.5->4 | ≤0.5 | >4 |
Quinupristin-dalfopristin | ≤0.12->4 | 0.25 | 0.5 |
Linezolid | ≤0.5-4 | 2 | 2 |
Ciprofloxacin | 0.25->8 | >8 | >8 |
Trimethoprim-sulfamethoxazole | ≤0.5->4 | ≤0.5 | >4 |
Gentamicin | 0.12->16 | 0.5 | >16 |
CoNS | |||
Methicillin susceptible (30) | |||
Telavancin | 0.12-0.25 | 0.25 | 0.25 |
Vancomycin | 0.5-2 | 1 | 2 |
Teicoplanin | ≤0.12-16 | 2 | 8 |
Daptomycin | 0.12-1 | 0.5 | 1 |
Oxacillin | ≤0.06-0.25 | 0.12 | 0.12 |
Erythromycin | ≤0.12->16 | 0.25 | >16 |
Telithromycin | ≤0.03->8 | 0.06 | 0.5 |
Clindamycin | ≤0.5->4 | ≤0.5 | ≤0.5 |
Quinupristin-dalfopristin | ≤0.12-0.25 | ≤0.12 | 0.25 |
Linezolid | 1-2 | 1 | 2 |
Ciprofloxacin | 0.12->8 | 0.12 | 0.25 |
Trimethoprim-sulfamethoxazole | ≤0.5->4 | ≤0.5 | >4 |
Gentamicin | ≤0.06->16 | ≤0.06 | ≤0.06 |
Methicillin resistant (50) | |||
Telavancin | 0.12-0.5 | 0.25 | 0.25 |
Vancomycin | 0.5-4 | 1 | 2 |
Teicoplanin | ≤0.12-16 | 2 | 8 |
Daptomycin | 0.12->1 | 0.5 | 0.5 |
Oxacillin | 0.5->4 | >4 | >4 |
Erythromycin | ≤0.12->16 | >16 | >16 |
Telithromycin | 0.06->8 | 0.12 | >8 |
Clindamycin | ≤0.5->4 | ≤0.5 | >4 |
Quinupristin-dalfopristin | ≤0.12->4 | 0.25 | 0.5 |
Linezolid | 1-4 | 2 | 2 |
Ciprofloxacin | ≤0.06->8 | 2 | >8 |
Trimethoprim-sulfamethoxazole | ≤0.5->4 | 2 | >4 |
Gentamicin | ≤0.06->16 | 8 | >16 |
Enterococcus faecalis | |||
Vancomycin susceptible (73) | |||
Telavancin | ≤0.015-0.5 | 0.25 | 0.5 |
Vancomycin | ≤0.5-4 | 2 | 2 |
Teicoplanin | ≤0.03-0.25 | 0.12 | 0.25 |
Daptomycin | ≤0.015-4 | 1 | 2 |
Ampicillin | ≤0.25-8 | 1 | 2 |
Linezolid | 1-4 | 2 | 2 |
Quinupristin-dalfopristin | 0.5-32 | 8 | 16 |
Ciprofloxacin | 0.5->32 | 1 | >32 |
Vancomycin resistant (7) | |||
Telavancin | 0.25-8 | 4 | 8 |
Vancomycin | 64->512 | 512 | >512 |
Teicoplanin | 0.06->128 | 32 | >128 |
Daptomycin | 0.5-2 | 0.5 | 2 |
Ampicillin | 1-4 | 1 | 4 |
Linezolid | 1-2 | 2 | 2 |
Quinupristin-dalfopristin | 8-16 | 8 | 16 |
Ciprofloxacin | 0.5->32 | 1 | >32 |
Enterococcus faecium | |||
Vancomycin susceptible (59) | |||
Telavancin | 0.03-0.5 | 0.12 | 0.25 |
Vancomycin | ≤0.5-2 | 1 | 1 |
Teicoplanin | ≤0.03-2 | 0.25 | 0.5 |
Daptomycin | 0.03-4 | 2 | 4 |
Ampicillin | 0.5->128 | 64 | 128 |
Linezolid | 1-4 | 2 | 2 |
Quinupristin-dalfopristin | 0.25-4 | 1 | 4 |
Ciprofloxacin | 0.25->32 | >32 | >32 |
Vancomycin resistant (21) | |||
Telavancin | 0.12-8 | 1 | 2 |
Vancomycin | 8->512 | 512 | 512 |
Teicoplanin | 0.12->128 | 32 | 128 |
Daptomycin | 0.25-4 | 2 | 2 |
Ampicillin | 1->128 | 128 | 128 |
Linezolid | 1-2 | 2 | 2 |
Quinupristin-dalfopristin | 0.25-4 | 1 | 4 |
Ciprofloxacin | 0.5->32 | 32 | >32 |
Streptococcus pneumoniae | |||
Penicillin susceptible (42) | |||
Telavancin | 0.008-0.06 | 0.015 | 0.03 |
Vancomycin | 0.25-0.5 | 0.25 | 0.5 |
Daptomycin | 0.06-0.5 | 0.12 | 0.25 |
Penicillin | ≤0.06-≤0.06 | ≤0.06 | ≤0.06 |
Cefuroxime | ≤0.12-0.25 | ≤0.12 | ≤0.12 |
Ceftriaxone | ≤0.015-0.12 | 0.03 | 0.03 |
Erythromycin | ≤0.015->1 | 0.03 | 0.06 |
Telithromycin | 0.004-0.25 | 0.008 | 0.008 |
Clindamycin | ≤0.03->0.25 | 0.06 | 0.06 |
Levofloxacin | 0.25-1 | 0.5 | 1 |
Trimethoprim-sulfamethoxazole | 0.12->4 | 0.25 | 1 |
Linezolid | 0.5-1 | 1 | 1 |
Tetracycline | ≤0.06->8 | 0.12 | 0.25 |
Penicillin intermediate (36) | |||
Telavancin | 0.008-0.06 | 0.015 | 0.03 |
Vancomycin | 0.25-0.5 | 0.25 | 0.5 |
Daptomycin | ≤0.03-0.5 | 0.12 | 0.25 |
Penicillin | 0.12-1 | 0.5 | 1 |
Cefuroxime | ≤0.12->4 | 0.5 | 4 |
Ceftriaxone | 0.03-1 | 0.12 | 1 |
Erythromycin | ≤0.015->1 | 0.03 | >1 |
Telithromycin | ≤0.002 | 0.008 | 0.25 |
Clindamycin | ≤0.03->0.25 | 0.06 | >0.25 |
Levofloxacin | 0.5-2 | 0.5 | 1 |
Trimethoprim-sulfamethoxazole | 0.12->4 | 4 | >4 |
Linezolid | 0.5-2 | 1 | 1 |
Tetracycline | ≤0.06->8 | 0.25 | >8 |
Penicillin resistant (22) | |||
Telavancin | 0.015-0.03 | 0.015 | 0.03 |
Vancomycin | 0.25-0.5 | 0.25 | 0.5 |
Daptomycin | 0.06-0.25 | 0.12 | 0.12 |
Penicillin | 2->2 | 2 | 2 |
Cefuroxime | 4->4 | >4 | >4 |
Ceftriaxone | 0.5-2 | 1 | 2 |
Erythromycin | 0.03->1 | >1 | >1 |
Telithromycin | 0.008-0.5 | 0.015 | 0.03 |
Clindamycin | 0.06->0.25 | >0.25 | >0.25 |
Levofloxacin | 0.5-8 | 0.5 | 4 |
Trimethoprim-sulfamethoxazole | 0.12->4 | 4 | >4 |
Linezolid | 0.5-1 | 1 | 1 |
Tetracycline | 0.12->8 | 0.25 | >8 |
Streptococcus group A (60) | |||
Telavancin | 0.03-0.06 | 0.03 | 0.06 |
Vancomycin | 0.25-0.5 | 0.25 | 0.5 |
Daptomycin | ≤0.03-0.5 | 0.06 | 0.06 |
Penicillin | ≤0.06-≤0.06 | ≤0.06 | ≤0.06 |
Cefuroxime | ≤0.12-≤0.12 | ≤0.12 | ≤0.12 |
Ceftriaxone | ≤0.015-0.06 | 0.03 | 0.03 |
Erythromycin | 0.03->1 | 0.03 | 0.06 |
Telithromycin | 0.008->4 | 0.015 | 0.015 |
Clindamycin | ≤0.03->0.25 | ≤0.03 | 0.06 |
Levofloxacin | ≤0.12-1 | 0.5 | 0.5 |
Trimethoprim-sulfamethoxazole | ≤0.06-0.25 | ≤0.06 | 0.25 |
Linezolid | 0.5-1 | 1 | 1 |
Tetracycline | 0.12->8 | 0.12 | >8 |
Streptococcus group B (60) | |||
Telavancin | 0.03-0.12 | 0.06 | 0.06 |
Vancomycin | 0.25-1 | 0.5 | 0.5 |
Daptomycin | 0.06-0.5 | 0.25 | 0.25 |
Penicillin | ≤0.06-≤0.06 | ≤0.06 | ≤0.06 |
Cefuroxime | ≤0.12-0.5 | ≤0.12 | ≤0.12 |
Ceftriaxone | 0.03-0.12 | 0.06 | 0.06 |
Erythromycin | 0.03->1 | 0.03 | 0.5 |
Telithromycin | 0.008-0.12 | 0.015 | 0.015 |
Clindamycin | ≤0.03->0.25 | 0.06 | 0.06 |
Levofloxacin | 0.25-1 | 0.5 | 1 |
Trimethoprim-sulfamethoxazole | ≤0.06-0.25 | ≤0.06 | 0.12 |
Linezolid | 0.5-1 | 1 | 1 |
Tetracycline | 0.12->8 | >8 | >8 |
Viridans streptococci (60) | |||
Telavancin | 0.015-0.12 | 0.06 | 0.06 |
Vancomycin | 0.25-1 | 0.5 | 1 |
Daptomycin | ≤0.03->1 | 0.5 | 1 |
Penicillin | ≤0.06->2 | ≤0.06 | 2 |
Cefuroxime | ≤0.12->4 | ≤0.12 | 2 |
Ceftriaxone | ≤0.015-4 | 0.12 | 2 |
Erythromycin | ≤0.015->1 | 0.03 | >1 |
Telithromycin | ≤0.002-0.25 | 0.008 | 0.12 |
Clindamycin | ≤0.03->0.25 | ≤0.03 | >0.25 |
Levofloxacin | 0.25->8 | 0.5 | 1 |
Trimethoprim-sulfamethoxazole | ≤0.06->4 | 0.25 | 2 |
Linezolid | 0.25-2 | 1 | 1 |
Tetracycline | ≤0.06->8 | 0.5 | >8 |